AXPERA
Pre-clinical- Indications
- Plant fungal diseases
Company intelligence / Profile preview
Amoéba
Chassieu/Lyon, Auvergne-Rhône-Alpes, Franceamoeba-nature.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Amoéba has developed a unique biological solution using the amoeba Willaertia magna C2c Maky. Their living form acts as a natural biocide for water, surfaces, and chronic wounds, while the lysed form serves as a biocontrol agent against plant pathogens. The company has shown promising preclinical results but awaits regulatory approvals before commercialization. They are publicly listed on Euronext Growth Paris since July 2015[1][3][4].
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Biological agents (living and lysed forms of Willaertia magna C2c Maky amoeba)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Nice & Green SAEuropean Investment Bank (EIB) – financing agreements[4]
Beyond the preview
Go deeper on Amoéba.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amoéba.